Tumor immunotherapy has garnered considerable attention, emerging as a new standard of
care in cancer treatment. The conventional targets, such as VEGF and EGFR, have been …

Simple Summary With the development of immunotherapies and targeted therapies in the
last years, there has been great progress in the outcome of patients with metastatic …

Abstract Purpose of Review The treatment strategy for BRAF-mutated melanoma remains
unsatisfactory, although the advent of immune checkpoint inhibition has improved the …

Melanoma is the deadliest form of skin cancer. It is classified as cutaneous and non-
cutaneous, with the former characterized by developing in sun-exposed areas of the skin …

Brain metastases stemming from lung cancer represent a common and challenging
complication that significantly impacts patients' overall health. The migration of these …

Novel therapies have achieved unprecedented benefit in survival of advanced melanoma
patients. While immunotherapy (ICI) can be administered independent of mutational status …

Skin cancer treatment is a combination of BRAF and MEK kinase inhibitors administered as
tablets, along with immunotherapy treatment (treatment into the vein) with a group of drugs …

Background Skin cutaneous melanoma (SKCM) poses a significant public health challenge
due to its aggressive nature and limited treatment options. To address this, the study …

Melanoma remains a formidable challenge in oncology, causing the majority of skin cancer
deaths in the United States, with brain metastases contributing substantially to this mortality …

Pregnancy-related gastric cancer is characterized by a refractory nature and poor prognosis;
few gastric cancer cases during pregnancy achieved acceptable outcomes by using anti-PD …